![Coronavirus: 499 morts de plus en France lors des dernières 24 heures, 3523 décès au total - L'Express Coronavirus: 499 morts de plus en France lors des dernières 24 heures, 3523 décès au total - L'Express](https://lexpress-lexpress-prod.web.arc-cdn.net/resizer/iesjJ_Qv3SSuiePKMFfwnOX80XQ=/1200x630/cloudfront-eu-central-1.images.arcpublishing.com/lexpress/RJDCZ4JULJCFHO4IKUCV2M7TNU.jpg)
Coronavirus: 499 morts de plus en France lors des dernières 24 heures, 3523 décès au total - L'Express
![BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers. - Abstract - Europe PMC BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers. - Abstract - Europe PMC](https://europepmc.org/articles/PMC8662740/bin/nihms-1731291-f0003.jpg)
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers. - Abstract - Europe PMC
![BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers | Science Translational Medicine BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers | Science Translational Medicine](https://www.science.org/cms/asset/aff01e29-3536-466a-9bbc-a839e7e344f4/aax2625-f1.gif)
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers | Science Translational Medicine
![BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers. - Abstract - Europe PMC BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers. - Abstract - Europe PMC](https://europepmc.org/articles/PMC8662740/bin/nihms-1731291-f0005.jpg)